Ramkrishna Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 19-05-2024
- Paid Up Capital ₹ 7.52 M
as on 19-05-2024
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2017
- Revenue %
(FY 2017)
- Ebitda
- Net Worth -1.75%
(FY 2017)
- Total Assets -0.29%
(FY 2017)
About Ramkrishna Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 7.52 M, as per Ministry of Corporate Affairs (MCA) records.
Kamlesh Upadhyay, Milindkuamr Dixit, and Virendra Dixit serve as directors at the Company.
- CIN/LLPIN
U24231GJ1995PLC025311
- Company No.
025311
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Apr 1995
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ramkrishna Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milindkuamr Dixit  | Managing Director | 22-Apr-1995 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kamlesh Upadhyay | Director | 01-Dec-2005 | Current |
| Virendra Dixit | Director | 21-Sep-1998 | Current |
Financial Performance and Corporate Structure Insights of Ramkrishna Pharmaceuticals.
Ramkrishna Pharmaceuticals Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 1.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ramkrishna Pharmaceuticals?
In 2017, Ramkrishna Pharmaceuticals had a promoter holding of 97.14% and a public holding of 2.86%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Balaji Fibrepack Private LimitedActive 23 years 8 daysMilindkuamr Dixit and Virendra Dixit are mutual person
- Rke Exports Private LimitedActive 21 years 5 months
Milindkuamr Dixit and Virendra Dixit are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ramkrishna Pharmaceuticals?
Unlock and access historical data on people associated with Ramkrishna Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ramkrishna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ramkrishna Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
